CD44 and cancer: Several miRNAs also regulate post-transcriptionally SLC7A11 levels, which is post-translationally stabilized by an interaction with CD44v9 (a variant of the CD44 stemness marker of several cancers) leading to inhibition of proteosomal degradation in cancer (Jyotsana et al., 2022).